Screening for Anxiety and Depression in people with psoriasis: a cross sectional study in a tertiary referral setting: A cross-sectional study in a tertiary referral setting

R.C. Lamb, Faith Matcham, M Turner, L Rayner, A Simpson, M Hotopf, J.N.W.N. Barker, K Jackson, C.H. Smith

Research output: Contribution to journalArticlepeer-review

82 Citations (Scopus)
441 Downloads (Pure)

Abstract

BACKGROUND National Institute for Health and Care Excellence (NICE) guidance recommends assessment of psychological and social well-being in people with psoriasis. OBJECTIVES To systematically screen for depression and anxiety in patients with psoriasis in routine clinical practice and identify at-risk groups for psychiatric morbidity. METHODS Consecutive patients attending a single, tertiary centre over a 10-month period were invited to complete Patient Health Questionnaire Depression Scale (PHQ-9), Generalized Anxiety Disorder Scale (GAD-7) and Dermatology Life Quality Index (DLQI) as part of the IMPARTS: Integrating Mental and Physical healthcare; Research, Training and Services. Information on demographics, treatment and clinical disease severity were collated from EPR. Regression models were used to identify at-risk groups for psychiatric morbidity. RESULTS Of 607 patients (56.2% on biologics) included, 9.9% (95%CI: 7.5-12.3%) screened positive for major depressive disorder and 13.1% (95%CI: 10.4-15.8%) for generalised anxiety disorder ([GAD] GAD-7 >9). Suicidal ideation was reported in 35% of MDD; DLQI was
Original languageEnglish
JournalBritish Journal of Dermatology
Early online date1 Jul 2016
DOIs
Publication statusPublished - 1 Jul 2016

Fingerprint

Dive into the research topics of 'Screening for Anxiety and Depression in people with psoriasis: a cross sectional study in a tertiary referral setting: A cross-sectional study in a tertiary referral setting'. Together they form a unique fingerprint.

Cite this